# Perspective Therapeutics, Inc. (CATX)

> Source: Nexqual · https://nexqual.com/CATX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Perspective Therapeutics, Inc. (CATX), nexqual.com/CATX" · informational, not investment advice.

**Price:** USD 2.34 (+4.46% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.24 · day 2.23–2.37 · 52w 1.96–6.16 · market cap $267M · ASE

## Key facts
- Analysts: Buy (mean 1.94 on a 1–5 scale) (16 analysts), mean target USD 12.29 (range 5–18).
- Total return with dividends: 1Y -50.7% vs S&P 500 +18.1%; 5Y -62.3% vs S&P 500 +85.1%.
- Next earnings: 2026-11-09, EPS estimate USD -0.25, revenue estimate $52K.

## Analysts
Consensus Buy (mean 1.94 on a 1–5 scale), 16 analysts; mean target USD 12.29 (low 5, high 18).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | BTIG | Reiterated | Buy | $14 |
| 2026-09-18 | William Blair | Initiated | Outperform |  |
| 2026-09-15 | Wedbush | Reiterated | Outperform | $11 |
| 2026-08-19 | BMO Capital | Initiated | Outperform | $11 |
| 2026-08-14 | B of A Securities | Target lowered | Neutral | $6 → $5 |
| 2026-08-11 | Piper Sandler | Target lowered | Overweight | $16 → $14 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -50.7% | -62.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -50.9% | -17.7% |
| Volatility (annualized) | 98.9% | 98.8% |
| Max drawdown | -60.4% (Feb 2026→Oct 2026) | -90.1% (Apr 2024→Mar 2025) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/CATX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt